Is Multiple Sclerosis Hereditary? Genetics, Family Risk and What Science Says in 2026

31 July 2026

MS is not a classically inherited disease — there is no single "MS gene" passed from parent to child. But genetics matters: general population risk is ~0.3%, a child of an affected parent 2–3%, a sibling 3–5%, an identical twin 25–30%. A review of 230+ risk genes, HLA-DRB1*15:01, familial MS, rare variants, and why the environment (EBV, vitamin D, smoking, obesity) decides whether those genes ever speak.

This is probably the first question people ask their neurologist after diagnosis: "Will I pass this to my children?" The answer is reassuring, but it needs nuance.

Multiple sclerosis is not hereditary in the classical (Mendelian) sense. There is no single gene passed from parent to child that causes the disease on its own, the way it works in cystic fibrosis or Huntington's disease. What is inherited is a susceptibility — a combination of hundreds of small genetic variants, each raising risk by only a few percent.

That susceptibility becomes disease only when it meets environmental triggers: Epstein-Barr virus infection, low vitamin D, smoking, adolescent obesity and gut microbiome composition. Genetics loads the gun; the environment pulls the trigger.

The actual numbers: how much risk do my relatives carry

These are the figures used by the National MS Society, MS Trust and European registries:

- General population: about 0.1–0.3% (1 in 300 to 1 in 1,000, depending on latitude).

- Child of an affected parent: about 2% (slightly higher if the mother is affected).

- Sibling of a person with MS: about 3–5%.

- Fraternal (non-identical) twin: about 5%.

- Identical twin: about 25–30%.

- Second-degree relative (aunt, uncle, grandchild): about 1%.

Note the single most important fact in MS genetics: in identical twins, who share 100% of their DNA, the second twin develops MS in at most 1 of 3 cases. That means at least 70% of the risk does not come from genes. Put differently: even with the "worst possible" genetic profile, the odds are still on your side.

Why family risk still feels big

A 3% figure sounds small, but when two or three people in the same family have MS it feels as if the disease is "running" through it. Three reasons:

1. Relative vs absolute risk. A sibling's risk is 10–20 times the population rate — impressive as a ratio, yet it still means 95–97% of siblings will never develop MS.

2. Shared environment. Family members share latitude, sun exposure, diet, smoking habits and the likelihood of early EBV infection. Part of "familial" risk is not genetic at all.

3. Familial MS is the minority. Only about 12–15% of patients have a relative with MS. The vast majority are the first case in their family — so-called sporadic MS.

What exactly are the "MS risk genes"

HLA-DRB1*15:01 — the strongest known link

Chromosome 6 carries the HLA (human leukocyte antigen) region, which determines how the immune system tells self from non-self. The HLA-DRB1*15:01 variant is the strongest single genetic risk factor for MS:

One copy raises risk roughly 3-fold. Two copies (one from each parent) raise it roughly 6-fold. The variant is common in Northern European populations, which explains part of the geographic gradient of MS.

Even so — millions of people carry HLA-DRB1*15:01 and never develop MS. The variant is a susceptibility factor, not a diagnosis.

200+ variants outside the HLA region

The largest international GWAS (International Multiple Sclerosis Genetics Consortium, *Science* 2019, 47,000+ patients and 68,000 controls) identified 233 independent genetic variants associated with MS risk. Almost all sit in genes that regulate the immune system — T and B lymphocytes, microglia, cytokine signalling. This was the definitive proof that MS is primarily an immune disease, not primarily a disease of nerve tissue.

Polygenic risk scores (PRS)

Adding all 233 variants into one number — a polygenic risk score — gives an estimate of an individual's genetic susceptibility. The catch: PRS currently explains only about 20–48% of MS heritability and is not accurate enough for clinical use. No major neurology society recommends genetic testing of healthy relatives today.

Rare variants and familial MS

Recent sequencing work (*Scientific Reports* 2025) showed that families with several affected members carry an increased burden of rare variants in the very genes flagged by GWAS. That explains why MS clusters in some families — but these variants are extremely rare and absent in most patients.

Progression genes — the new frontier

Until 2023 all MS genetics was about *who gets the disease*. Then the IMSGC published the first variant linked to the speed of disability progression — near the DYSF and ZNF638 genes, active in nerve tissue rather than the immune system. The message: the genes that decide *whether* you get MS are not the genes that decide *how fast* it progresses. This is now the most active research field (reviewed in *Current Opinion in Neurology* 2026).

Environment: where it is actually decided

If genes explain at most a third of the risk, the rest comes from the environment. The best-documented factors:

- Epstein-Barr virus (EBV). A Harvard study of 10 million military recruits (*Science* 2022) found a 32-fold increased risk of MS after EBV infection. EBV is now considered a near-necessary condition. More in [Epstein-Barr virus and MS](post20).

- Low vitamin D and low sun exposure. Explains much of the geographic gradient. More in [Vitamin D and MS](post32).

- Smoking. Raises risk ~1.5-fold and accelerates progression; childhood passive smoking counts too.

- Adolescent obesity. Roughly doubles risk, independently of genes.

- Gut microbiome. Recent work links the Lachnospiraceae family to triggering the autoimmune response — see [Gut bacteria and MS](post91).

Why this is good news: genes cannot be changed, the environment can. It is the only part of the equation a family actually controls.

Should I get a genetic test?

Short answer: no, if you are healthy. Reasons:

The test cannot predict whether you will develop MS — neither a positive HLA-DRB1*15:01 nor a high PRS is a diagnosis. There is no preventive therapy that the result would change. The result can cause unnecessary anxiety and insurance problems in some countries.

Genetic counselling makes sense only in rare situations: multiple affected members across generations, very early childhood onset, or suspicion of rare inherited diseases that mimic MS (CADASIL, leukodystrophies, mitochondrial disease). That is differential diagnosis, not risk prediction.

What to tell your children and partner

A practical framework used by MS counsellors:

1. Use concrete numbers. "97 out of 100 children of a parent with MS will never get MS" is both more accurate and less frightening than "there is a risk".

2. Do not hide the diagnosis from children. Children sense tension; an age-appropriate explanation reduces fear far more than silence.

3. Family planning does not change because of MS. Pregnancy even temporarily reduces disease activity — see [MS and pregnancy](post10).

4. Point the family at environmental factors: a smoke-free home, vitamin D checks, healthy weight, physical activity. Those are the only proven levers.

What to expect by 2030

- Better polygenic scores including non-European populations (the vast majority of current data comes from European cohorts — a major blind spot).

- Progression genetics guiding treatment choice: patients with a fast-progression genetic profile would receive high-efficacy drugs early.

- Gene–environment interaction: predicting who will actually develop MS after EBV infection.

- An EBV vaccine as genuine prevention — more in [EBV vaccine Horizon](post6).

Multiple sclerosis is not inherited the way eye colour is. What is inherited is susceptibility, spread across more than 230 genes, none of which causes the disease alone. Your child's risk is about 2%, a sibling's 3–5%, and even in an identical twin it stays below 30%. Everything else is decided by viruses, sunlight, cigarette smoke and lifestyle. If MS runs in your family, the most useful thing you can do is not a genetic test — it is a smoke-free home, adequate vitamin D, a healthy weight and attention to early symptoms.

Related reading: [Is MS hereditary — the basics](post60), [Why women are affected more often](post88) and [How to recognise MS](post40).

Sources

International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 2019;365:eaav7188. International Multiple Sclerosis Genetics Consortium. Locus for severity implicates CNS resilience in progression of multiple sclerosis. Nature 2023;619:323–331. Patsopoulos NA. Genetics of Multiple Sclerosis: An Overview and New Directions. Cold Spring Harb Perspect Med 2018;8:a028951. Willer CJ et al. Twin concordance and sibling recurrence rates in multiple sclerosis. PNAS 2003;100:12877–12882. Bjornevik K et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 2022;375:296–301. Increased burden of rare variants in GWAS associated genes in familial multiple sclerosis. Scientific Reports 2025. The genetics of multiple sclerosis: an updated perspective. Current Opinion in Neurology 2026. National MS Society — What Causes MS? / Is MS Genetic? (2025). MS Trust — Genetics and MS. MyMSTeam — Is Multiple Sclerosis Hereditary? This article is educational and does not replace medical advice or genetic counselling.